Antigen Candidates for Atherosclerosis Vaccine Development

D. K.S.C. Putri, M. J. Al-Farabi, I. G.R. Suryawan

Research output: Contribution to journalConference articlepeer-review

1 Citation (Scopus)

Abstract

Atherosclerosis is a major cardiovascular issue in the world. Atherosclerosis has long been theorized to be originated from foam cells that build up due to the chronic inflammatory process of cholesterol deposition in the walls of blood vessels and the uptake of oxidized LDL (OxLDL) and phosphorylcholine. Until now, the treatment for atherosclerosis has been focusing on drugs that inhibit the progression of atherosclerotic plaques. Recent findings show that proper regulation of immune cells, both adaptive and innate, has been shown to have a relationship with the prevention of atherosclerotic lesions. The future of vaccination as prevention for atherosclerosis holds great potential, considering studies are abundant in proving the atheroprotective effects of the immunization with several types of antigens. In this literature review, we will discuss the types of antigens which hold promising potentials for atherosclerosis vaccine development and its future challenges.

Original languageEnglish
Article number012164
JournalIOP Conference Series: Earth and Environmental Science
Volume441
Issue number1
DOIs
Publication statusPublished - 24 Feb 2020
Event2nd International Conference on Fisheries and Marine Science, InCoFiMS 2019 - Surabaya, Indonesia
Duration: 26 Sept 2019 → …

Fingerprint

Dive into the research topics of 'Antigen Candidates for Atherosclerosis Vaccine Development'. Together they form a unique fingerprint.

Cite this